Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Albertini

Showing results (151-160 of 221) with videos related to

Pageof 23
Sort By:
Investigational New Drugs|February 19, 2011
Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcomaSteven J O'Day, Anna C Pavlick, Mark R Albertini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696John M Kirkwood, Sandra Lee, Stergios J Moschos, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blastsP Lunghi, A Tabilio, S Pinelli, et al.
Journal of Inorganic Biochemistry|May 15, 1995
2,6-diacetylpyridine bis(thiosemicarbazones) zinc complexes: synthesis, structure, and biological activityM C Rodriguez-Argüelles, M Belicchi Ferrari, G Gasparri Fava, et al.
Multiple Sclerosis International|November 22, 2013
Growth hormone and disease severity in early stage of multiple sclerosisM Gironi, C Solaro, C Meazza, et al.
Brain Research|February 28, 2008
PPADS, a purinergic antagonist reduces Fos expression at spinal cord level in a mouse model of mononeuropathyE Borsani, R Albertini, M Colleoni, et al.
Human Gene Therapy|September 19, 1998
Development of human granulocyte-macrophage colony-stimulating factor-transfected tumor cell vaccines for the treatment of spontaneous canine cancerG S Hogge, J K Burkholder, J Culp, et al.
The American Journal of Dermatopathology|July 28, 2025
Malignant Melanoma With Transdifferentiation Into a Ganglioneuroblastic Phenotype After Anti-PD-1 TherapyMadison S Harris, Claire Castaneda, Aaron Wieland, et al.
Journal of Inorganic Biochemistry|July 9, 1998
Diorganotin(IV) complexes of pyridoxal thiosemicarbazone: synthesis, spectroscopic properties and biological activityJ S Casas, M C Rodríguez-Argüelles, U Russo, et al.
Diabetes Research and Clinical Practice|February 18, 2014
Effects of uncomplicated vaginal delivery and epidural analgesia on fetal arterial acid-base parameters at birth in gestational diabetesF Beneventi, E Locatelli, C Cavagnoli, et al.
Pageof 23

Showing results (151-160 of 221) with videos related to

Sort By:
Pageof 23
Investigational New Drugs|February 19, 2011
Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcomaSteven J O'Day, Anna C Pavlick, Mark R Albertini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696John M Kirkwood, Sandra Lee, Stergios J Moschos, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blastsP Lunghi, A Tabilio, S Pinelli, et al.
Journal of Inorganic Biochemistry|May 15, 1995
2,6-diacetylpyridine bis(thiosemicarbazones) zinc complexes: synthesis, structure, and biological activityM C Rodriguez-Argüelles, M Belicchi Ferrari, G Gasparri Fava, et al.
Multiple Sclerosis International|November 22, 2013
Growth hormone and disease severity in early stage of multiple sclerosisM Gironi, C Solaro, C Meazza, et al.
Brain Research|February 28, 2008
PPADS, a purinergic antagonist reduces Fos expression at spinal cord level in a mouse model of mononeuropathyE Borsani, R Albertini, M Colleoni, et al.
Human Gene Therapy|September 19, 1998
Development of human granulocyte-macrophage colony-stimulating factor-transfected tumor cell vaccines for the treatment of spontaneous canine cancerG S Hogge, J K Burkholder, J Culp, et al.
The American Journal of Dermatopathology|July 28, 2025
Malignant Melanoma With Transdifferentiation Into a Ganglioneuroblastic Phenotype After Anti-PD-1 TherapyMadison S Harris, Claire Castaneda, Aaron Wieland, et al.
Journal of Inorganic Biochemistry|July 9, 1998
Diorganotin(IV) complexes of pyridoxal thiosemicarbazone: synthesis, spectroscopic properties and biological activityJ S Casas, M C Rodríguez-Argüelles, U Russo, et al.
Diabetes Research and Clinical Practice|February 18, 2014
Effects of uncomplicated vaginal delivery and epidural analgesia on fetal arterial acid-base parameters at birth in gestational diabetesF Beneventi, E Locatelli, C Cavagnoli, et al.
Pageof 23